In celebration of World Malaria Day 2025, Emzor Pharmaceutical Industries Limited has reaffirmed its dedication to combating malaria across Nigeria and the wider Sub-Saharan region. The pharmaceutical giant marked the day with community-focused initiatives, including free health screenings and the distribution of antimalarial drugs to vulnerable populations, particularly pregnant women and children under five.
During the event, Emzor’s Head of Marketing and Strategy, Kunle Faloye, stated that the company remains committed to supporting local and international efforts to eradicate malaria.
“For years, Emzor has been at the forefront of malaria prevention and treatment, producing high-quality antimalarial medications that are both accessible and affordable for millions across Africa,” he said.
This year’s World Malaria Day theme, “Malaria Ends With Us: Reinvest, Reimagine, Reignite,” closely reflects Emzor’s mission to impact the fight against malaria significantly.
According to the company, their efforts span the development, production, and distribution of over 20 different antimalarial drug formulations, including widely used combinations like Artemether/Lumefantrine (Lokmal) and Sulfadoxine/Pyrimethamine (Maldox).
Faloye emphasised that Emzor’s strategic research investments and extensive distribution network have been critical in reducing the malaria burden in many African communities.
Highlighting the company’s long-term vision, Emzor’s Chairman of the Board, Emeka Okoli, spoke on the firm’s ongoing investment in the local production of Active Pharmaceutical Ingredients (APIs) at its manufacturing campus in Sagamu, Ogun State.
“With approximately 95 per cent of all malaria cases and 96 per cent of the deaths occurring on the continent, this is predominantly an African problem and hence, the solutions should also largely come from the continent,” Okoli noted.
The Sagamu plant, which focuses on manufacturing key malaria-fighting APIs such as Artemether, Lumefantrine, Sulfadoxine, and Pyrimethamine, aims to strengthen Nigeria’s pharmaceutical self-sufficiency and reduce reliance on imports.
Beyond production, Emzor continues collaborating with government agencies, NGOs, and local communities to implement grassroots initiatives centered on malaria education, prevention, diagnosis, and treatment. The company’s programs include the regular provision of subsidised and free medications for the most at-risk populations.
“As we mark this important day, Emzor remains steadfast in our resolve to contribute to global efforts toward malaria eradication. We will continue to innovate, collaborate, and invest in sustainable healthcare solutions that enhance lives across Nigeria and the continent,” Faloye concluded.
World Malaria Day is observed every April 25 to raise awareness of the global fight against malaria and to promote strategies for prevention, treatment, and eventual eradication of the disease.
